Dr.
Thomas Alexander Waldmann
(
–
)
1930
2021
National Cancer Institute
;
Bethesda, MD
Physician; Immunologist; Government research agency administrator
Area
Biological Sciences
Specialty
Medical Sciences
Elected
1989
His recent studies have focused on the role played by the Interleukin 2/interleukin 2 receptors (IL-2R) system in the growth and differentiation of normal and neoplastic lymphocytes. He also co-discovered IL-15. He has introduced various forms of IL-2R and IL-15R directed therapy for leukemia, and autoimmune diseases and to prevent allograft rejection that use monoclonal antibodies developed in his laboratory.
Last Updated